Sialic acid capping of CD8β core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction

71Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Bidentate interaction of a T-cell receptor and CD8αβ heterodimer with a peptide-MHCI complex is required for the generation of cytotoxic T-lymphocytes. During thymic development, the modification of CD813 glycans influences major histocompatibility complex class I binding to T-cell precursors called thymocytes. ES mass spectrometry (MS) and tandem MS/MS analysis were used to identify the changes occurring in the CD8β-glycopeptides during T-cell development. Several threonine residues proximal to the CD8β Ig headpiece are glycosylated with core-type 1 O-glycans. Non-sialylated glycoforms are present in immature thymocytes but are virtually absent in mature thymocytes. These results suggest how sialylation in a discrete segment of the CD8β stalk by ST3Gal-1 sialyltransferase creates a molecular developmental switch that affects ligand binding.

Cite

CITATION STYLE

APA

Moody, A. M., North, S. J., Reinhold, B., Van Dyken, S. J., Rogers, M. E., Panico, M., … Reinherz, E. L. (2003). Sialic acid capping of CD8β core 1-O-glycans controls thymocyte-major histocompatibility complex class I interaction. Journal of Biological Chemistry, 278(9), 7240–7246. https://doi.org/10.1074/jbc.M210468200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free